The Neuroimmune Signature Underlying HPV Infection and Cervical Cancer Progression
Persistent infection with high-risk human papillomavirus (HPV) is the principal cause of cervical cancer, yet the multicellular signalling programmes that accompany disease progression remain incompletely defined. Here, we integrated Single cell RNA sequencing, independent microarray and bulk RNA-sequencing meta analyses, and TCGA CESC tumor data to characterize the neuroimmune transcriptional architecture of HPV associated cervical disease. Single cell profiling revealed progressive remodeling of epithelial, stromal, endothelial and immune compartments across HPV infection, high grade squamous intraepithelial lesions and cervical cancer. Although immune dysregulation predominated, lesion and tumor states showed coordinated enrichment of nervous system associated programs, including synapse organization, trans-synaptic signaling, axon development, neurogenesis and neurotransmitter-related signaling. These programs formed interconnected networks with cytokine production, leukocyte activation, chemotaxis, cell adhesion, apoptosis, and immune effector regulation. Cross-platform integration identified a recurrent 12-gene neuroimmune signature associated with tumor grade related transcriptional variation, including CXCL12, P2RY6, P2RX5 and TACR1. Ligand receptor inference further highlighted glutamatergic, adrenergic, noradrenergic, GABAergic and purinergic signaling circuits. Notably, these signals were distributed across immune, epithelial, stromal and endothelial populations rather than confined to a canonical neural cell compartment. P2RX5 showed the strongest association with advanced tumor grade, whereas P2RY6, P2RY11 and GABRP displayed cell type and stage dependent regulation. Together, our findings define cervical carcinogenesis as a distributed neuroimmune state in which HPV associated immune evasion converges with ectopic neurotransmission-related programs, revealing candidate biomarkers and potentially actionable signaling axes in the cervical tumor microenvironment.
Authors
- Fernando Yuri Nery do Vale (ORCID: https://orcid.org/0000-0003-1763-343X)
- Otávio Cabral-Marques (ORCID: https://orcid.org/0000-0002-3183-6236)
- Rohini Sharma (ORCID: https://orcid.org/0000-0003-2441-549X)
- Rodrigo Juliani Siqueira Dalmolin (ORCID: https://orcid.org/0000-0002-1688-6155)
- Roseane Galdioli Nava (ORCID: https://orcid.org/0000-0001-7415-2136)
- Igor Salerno Filgueiras (ORCID: https://orcid.org/0000-0002-3493-4464)
- Júlia Nakanishi Usuda (ORCID: https://orcid.org/0000-0002-1516-162X)
- Anny Silva Adri (ORCID: https://orcid.org/0009-0007-0275-6126)
- Yohan Lucas Gonçalves Corrêa (ORCID: https://orcid.org/0009-0005-1024-2454)
- Ronaldy Santana Santos (ORCID: https://orcid.org/0000-0002-4928-7802)
- Haroldo Dutra Dias (ORCID: https://orcid.org/0009-0001-1884-5373)
- H D Ochs
- Lena Marques
- Cabral Gustavo
- Amanda Rodriguez Valera
- Adriel Leal Nobile
- Debora Albuquerque
Institutions
- Royal College of Surgeons in Ireland (IE)
- Universidade de São Paulo (BR)
- Hammersmith Hospital (GB)
- Universidade Federal do Rio Grande do Norte (BR)
- Seattle Children's Hospital (US)
- Imperial College London (GB)
- Universidade Federal de São Paulo (BR)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2026-11-19
- DOI
- https://doi.org/10.64898/2026.11.17.766177
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- preprint